| Literature DB >> 16311700 |
Enrique Valdés1, Tatiana Núñez, Daniel Pedraza, Hernán Muñoz.
Abstract
Impetigo Herpetiformis is a high-risk gestational skin disease that represents a risk for both the mother and offspring. Its management is based on multisystemic support and maternal steroid therapy. When these measures are insufficient to control the disease, the association of ciclosporine to the treatment has been proposed. We report a 24 year-old woman with a 16 weeks pregnancy, that presented with Impetigo Herpetiformis. The disease was refractory to the use of steroids, the patient had a metabolic decompensation and a dehydration with electrolyte imbalance. Therefore, treatment with ciclosporine was initiated and a rapid regression of the lesions was observed. Gestation was maintained, with a good perinatal outcome.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16311700 DOI: 10.4067/s0034-98872005000900011
Source DB: PubMed Journal: Rev Med Chil ISSN: 0034-9887 Impact factor: 0.553